A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

著者: Giovanni Grignani, Emanuela Palmerini, Palma Dileo, Sebastian Dorin Asaftei, Lorenzo D’Ambrosio, Ymera Pignochino, M. Mercuri, Piero Picci, Franca Fagioli, Paolo G. Casali, Stefano Ferrari, Massimo Aglietta - Annals of Oncology 2011 被引用: 356